133 related articles for article (PubMed ID: 21692613)
1. A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
Newman WG; Payne K; Tricker K; Roberts SA; Fargher E; Pushpakom S; Alder JE; Sidgwick GP; Payne D; Elliott RA; Heise M; Elles R; Ramsden SC; Andrews J; Houston JB; Qasim F; Shaffer J; Griffiths CE; Ray DW; Bruce I; Ollier WE;
Pharmacogenomics; 2011 Jun; 12(6):815-26. PubMed ID: 21692613
[TBL] [Abstract][Full Text] [Related]
2. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
3. An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.
Vestergaard T; Bygum A
Clin Exp Dermatol; 2010 Mar; 35(2):140-4. PubMed ID: 19663853
[TBL] [Abstract][Full Text] [Related]
4. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
[TBL] [Abstract][Full Text] [Related]
5. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
[TBL] [Abstract][Full Text] [Related]
7. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
8. Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity.
Kolorz M; Bartosova L; Hosek J; Dvorackova D; Chylkova A; Zboril V; Batovsky M; Bartos M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():137-42. PubMed ID: 20027160
[TBL] [Abstract][Full Text] [Related]
9. Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Casajús A; Zubiaur P; Méndez M; Campodónico D; Gómez A; Navares-Gómez M; Villapalos-García G; Soria-Chacartegui P; Novalbos J; Román M; Mejía-Abril G; Ochoa D; Abad-Santos F
Adv Ther; 2022 Apr; 39(4):1743-1753. PubMed ID: 35192152
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
11. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
Heneghan MA; Allan ML; Bornstein JD; Muir AJ; Tendler DA
J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
14. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
15. Combined evaluation of genotype and phenotype of thiopurine S-methyltransferase (TPMT) in the clinical management of patients in chronic therapy with azathioprine.
Rucci F; Cigoli MS; Marini V; Fucile C; Mattioli F; Robbiano L; Cavallari U; Scaglione F; Perno CF; Penco S; Marocchi A
Drug Metab Pers Ther; 2019 Mar; 34(1):. PubMed ID: 30840585
[TBL] [Abstract][Full Text] [Related]
16. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
[TBL] [Abstract][Full Text] [Related]
17. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG
Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
